| Nicole Elizabeth Cornelio, PA | |
|
2800 Main St, Bridgeport, CT 06606-4201 | |
| (203) 576-6000 | |
| Not Available |
| Full Name | Nicole Elizabeth Cornelio |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 2800 Main St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699416461 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Elizabeth Cornelio, PA 86 Barholm Ave, Stamford, CT 06907-1304 Ph: (203) 550-6354 | Nicole Elizabeth Cornelio, PA 2800 Main St, Bridgeport, CT 06606-4201 Ph: (203) 576-6000 |
News Archive
In a SciDev.Net editorial, David Dickson, director of SciDev.Net, examines progress towards the Millennium Development Goal (MDG) targets, highlighting their usefulness as well as their shortcomings. "The value of the MDGs lies in the way they have acted as both a carrot and a stick to focus the efforts of both development agencies and governments of developing countries," according to Dickson, who writes that "the curse of the MDGs is that they focus on relatively short-term, concrete objectives, and lack sufficient 'buy-in' from the very countries they are intended to help.
Using MRI to study the brains of young female athletes has helped researchers develop an objective way to monitor a concussion injury.
AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) announced overall survival (OS) for tivozanib, an investigational agent, from the Phase 3 TIVO-1 (TIvozanib Versus sOrafenib in 1st line advanced RCC) study in patients with advanced renal cell carcinoma (RCC). The final OS analysis, as specified by the protocol, shows a median OS of 28.8 months (95% confidence interval [CI]: 22.5–NA) for tivozanib versus a median OS of 29.3 months (95% CI: 29.3–NA) for the comparator arm, sorafenib.
For children with rare, aggressive and advanced cancer, precision medicine may help doctors determine their best treatment options, a new study finds.
› Verified 4 days ago
Mr. Alex Scott Cadan, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-4500 Fax: 203-384-3812 | |
Daniel Paoletti, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-6000 | |
Ms. Katie Lynn Merithew, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3199 | |
Alan Olson, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3000 | |
Margaret Parisi, PA-S Physician Assistant Medicare: Medicare Enrolled Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-6000 | |
Mr. Michael Asare, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3000 | |
Brent M Reilly, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, St.vincents Multispecialty Group, Bridgeport, CT 06606 Phone: 203-576-6000 |